Acrylamide intoxication produces peripheral neuropathy characterized by weakness and ataxia in both humans and experimental animals. Previous studies on animals of different ages and species indicate that the longest and largest nerves are affected earlier with the major pathology in the terminal parts of axons, i.e., distal axonopathy. However, several issues have remained elusive; for example, what are the earliest pathological changes? An equally intriguing question is whether younger animals are more susceptible to acrylamide than older animals. To address these issues, we compared the vulnerability to acrylamide of 3-and 8-week-old mice. These mice were intoxicated with acrylamide in drinking water (400 ppm). The sequence of intoxication could be categorized into three stages. In the initial stage, there was no visible weakness or ataxia. The only noticeable changes were poor performance on the rota-rod test and swelling of motor nerve terminals. Obvious weakness and ataxia of hindlimbs developed gradually (here designated as the early stage). The weakness and ataxia progressed at variable speeds in mice of different ages, and eventually the forelimbs (quadriparesis) were affected in the late stage. Each stage appeared earlier in 3-week-old mice than in 8-week-old mice (7.1 ؎ 1.1 vs 15.6 ؎ 4.0 days, P F 0.01 for the early stage; and 15.3 ؎ 2.1 vs 31.7 ؎ 6.0 days, P F 0.01 for the late stage). The progression of neurological deficits was also faster in the younger mice (7.2 ؎ 1.8 vs 16.3 ؎ 4.2 days, P F 0.01). Pathological changes in the distal parts of motor nerves innervating hindfoot muscles were evaluated by combined cholinesterase histochemistry and immunocytochemistry for neuronal markers to demonstrate motor nerve terminals and neuromuscular junctions simultaneously. In the initial stage, there was axonal swelling in motor nerve terminals. As acrylamide intoxication continued, axonal swelling extended into junctional folds and into the intramuscular nerves, which resulted in Wallerian-like degeneration. Our results indicate that younger mice show a much higher susceptibility to acrylamide intoxication, and pathological changes precede neurological symptoms.
INTRODUCTION
Acrylamide produces weakness and ataxia in both humans and experimental animals (10, 13, 20, 23) . Early manifestations of acrylamide intoxication appear in the hindlimbs. The neurological deficits eventually progress to forelimbs with quadriparalysis. Impairment of motor system, failure of cerebellar connection, and degeneration of large sensory nerves all contribute to neurological manifestations of acrylamide intoxication. Among these systems, motor nerves have been extensively characterized (3, 26) . Pathologically, the longest and the largest axons in both peripheral and central nerves are the most susceptible ones, and the major changes are in the most distal parts of axons (24, 25) . Characteristic findings include accumulation of neurofilaments and organelles followed by Wallerianlike degeneration (6, 16, 21) . Axonal swelling affecting neuromuscular junctions contributes to the development and progression of weakness after intoxication (11) . However, there is only limited literature correlating behavioral abnormalities with early pathological findings and their evolution (8, 33) .
In many aspects, distal filamentous pathology and nerve degeneration after acrylamide intoxication mimic various kinds of peripheral nerve disorders, and acrylamide neuropathy provides an experimental system to study degeneration and regeneration of axons (35) . As many novel therapeutic strategies are under way for trials on peripheral nerve degeneration, a multidisciplinary approach with quantification of various parameters will be important for evaluating potential therapeutic strategies, such as neurotrophins (1, 18, 19) .
After acrylamide intoxication, there is a time lag before the appearance of neurological abnormalities. Effects of acrylamide intoxication are dose-dependent (2, 10) . Previous studies have mainly focused on adult animals, and only a few observations have explored the issue of age on the susceptibility to acrylamide (5, 9, 27) . During maturation of the nervous system, there is an extensive reorganization of axonal structures, and the effects of acrylamide during this process remain elusive.
To address these issues, we compared neurotoxic effects on weaning and adult mice by a multidisciplinary approach including functional, neurophysiologic, and pathological examinations. Specifically, we asked whether there is a difference in the onset and progression of neurological symptoms and signs between 3-and 8-week-old mice after acrylamide intoxication. Our findings indicate that the 3-week-old weaning mice were more susceptible to acrylamide intoxication than the 8-week-old adult mice. The difference should provide insights into the mechanisms of acrylamide toxicity.
MATERIALS AND METHODS

Acrylamide Intoxication
Intoxication of acrylamide (Merck, Darmstadt, Germany) began with groups of 3-week-old (3W group) and 8-week-old (8W group) male ICR mice. Animals were housed four to five per cage in plastic boxes throughout the experimental period. Acrylamide was added to the drinking water (400 ppm). Control mice drank regular water. Experimental procedures followed the principles in the ''Use of Animals in Toxicology'' and NIH guidelines (''Guide for the Care and Use of Laboratory Animals,'' NIH Publication No. 1985) .
Rota-Rod Test
The rota-rod test followed previous protocols (9, 14, 32) . Briefly, the Rota-Rod Treadmill for Mice (UGO Basile, Italy) was used to measure the degree of motor dysfunction in control and acrylamide-intoxicated mice. Three days prior to intoxication, mice were trained to maintain their balance on the rod at a speed of 8 rpm for 120 s. Each day we recorded the duration during which the mouse stayed on the rod. There were three trials with an interval of 20 min between trials, and the mean of the three trials was used for further analysis.
Electrophysiological Studies
A nerve conduction study was performed to evaluate the functions of peripheral nerves with the measurement of compound muscle action potentials (CMAP) following the modified procedure (17) . At the onset of each stage, mice were anesthetized with 4% chloral hydrate and restrained on a warm plate to keep the surface temperature of the tail at or above 30°C. Two pairs of electrodes were inserted into the tail to record the CMAP with a stimulus intensity of 7 V and 10 ms. We recorded the latency to the onset of CMAP and the amplitude of the peak of CMAP. Nerve conduction velocities were calculated and analyzed as well.
Combined Cholinesterase Histochemistry and Immunocytochemistry
At various intervals after the development of behavioral abnormalities, both intoxicated and control mice were sacrificed by intracardiac perfusion with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). For morphological examination, the paraformaldehydefixed plantar muscles were carefully removed under a dissecting microscope, postfixed in the same fixative overnight, and then cryoprotected with 30% sucrose in 0.1 M phosphate buffer. Serial 30-µm cryostat sections were cut and mounted on gelatin-coated slides. Every fifth section was analyzed by cholinesterase histochemistry and immunocytochemistry for protein gene product 9.5 (PGP) as described previously (4) . PGP is a tissue-specific ubiquitin carboxyl-terminal hydrolase present in all types of neurons and peripheral nerve fibers. This method demonstrates neuromuscular junctions (blue) and innervating axons (brown). Briefly, after quenching with 1% H 2 O 2 in methanol, the sections were washed in 0.5 M Tris buffer, pH 7.6 (Tris), and incubated with 0.5% fat-free dry milk in Tris. The sections were incubated with PGP (1:1000, UltraClone, UK) at 4°C overnight. After washing with Tris, the biotinylated goat anti-rabbit IgG was applied at room temperature for 1 h. Following the avidin-biotin method (Vector, Burlingame, CA), the reaction products were detected with 0.05% 3,3Ј-diaminobenzidine tetrahydrochloride (DAB). The integrity of axons within neuromuscular junctions was evaluated under a Zeiss Axiophot microscope (Carl Zeiss, Germany) in a blinded fashion. We calculated the ratios of innervated and abnormal neuromuscular junctions (with axonal swelling) to all neuromuscular junctions.
Ultrastructural Study
Following perfusion with 4% paraformaldehyde in 0.1 M phosphate buffer, the plantar muscles was removed and fixed in 5% glutaraldehyde overnight at 4°C. The specimens were reacted with bromoindoxyl acetate to localize neuromuscular junctions as described before (7) . Blocks with neuromuscular junctions were postfixed in osmium tetraoxide, dehydrated through graded ethanol, and embedded in Epon. Semithin sections were stained with toluidine blue. Selected areas with intramuscular nerves were thin-sectioned, observed, and photographed under a Hitachi electron microscope.
Study Design and Statistical Analysis
For each mouse, body weight, presence or absence of neurological signs (the pattern of walking), and performance on the rota-rod test were recorded every day. The amount of water intake in each cage was measured every day as well. Based on the data of a preliminary study to determine the onset of the early and late stages, we carried out neurophysiological and pathological examinations in the middle of each stage. The total number of mice used for pathological studies is listed in Table 1 . The measurement and interpretation of the results were performed by an independent observer blinded to the information of intoxication. Data were expressed as means Ϯ SD. ANOVA with post hoc test and Student's t test were used to compare control and intoxicated mice. Any difference with P Ͻ 0.05 was considered statistically significant.
RESULTS
Stereotyped Neurological Abnormalities after Acrylamide Intoxication
Acrylamide intoxication produced stereotyped and progressive weakness and unsteady gaits. Control mice walked with plantar surfaces touching the floor (Fig.  1A) . At the start of acrylamide intoxication, the walking pattern of acrylamide-intoxicated mice without visible neurological abnormalities was similar to that of the control mice. This phase was designated as the initial stage. Mice intoxicated with acrylamide developed an unsteady walking pattern with abduction and external rotation of hindlimbs. The mice which walked with a paralytic gait were in the early stage of intoxication (Fig. 1B) . As intoxication continued, weakness and ataxia of hindlimbs became evident. Gradually, the mice dragged their feet as they walked (Fig. 1C) . Finally the weakness of the most severely intoxicated mice included the forelimbs. When the mice had quadriparalysis, they were in the late stage (Fig. 1D) .
Both age groups of intoxicated mice showed the same progressive pattern of neurological abnormalities, but with different chronologies of onset and progression of each stage. The onset of the early stage in the 3W group was earlier than that in the 8W group (7.1 Ϯ 1.1 vs 15.6 Ϯ 4.0 days, P Ͻ 0.01) ( Fig. 2A) . The late stage started 15.3 Ϯ 2.1 days after intoxication in the 3W group and 31.7 Ϯ 6.0 days in the 8W group (P Ͻ 0.01) (Fig. 2B) . The progression from the early stage to the late stage was faster in the 3W group than in the 8W group (7.2 Ϯ 1.8 vs 16.3 Ϯ 4.2 days, P Ͻ 0.01).
Age-and Dose-Dependent Neurotoxicity of Acrylamide
Consistent with previous observations, there was a significant decrease in body weight in both age groups of mice (Fig. 3) . In the beginning of the experiment, body weights of the 3W group were 11.8 Ϯ 2.1 g, and those of the 8W group were 33.8 Ϯ 3.2 g. Control 3-week-old mice exhibited a progressive increase of body weight. But the acrylamide-intoxicated mice at the late stage had growth retardation, with a body weight of 10.2 Ϯ 4.2 g, significantly smaller than that of the control mice (31.1 Ϯ 2.1 g). The 8W group had a 29% decrease in body weight (24.0 Ϯ 8.1 g for intoxicated mice and 40.1 Ϯ 1.6 g for control mice). A possible confounding factor for the differential onset and progression of acrylamide intoxication might be a difference in the ingestion of acrylamide.
FIG. 2.
Onset of neurological symptoms in mice of different ages. The cumulative frequency plots show the onset of the early and late stages of acrylamide intoxication in 3-week-old (3W) and 8-week-old (8W) mice. The early stage was defined as mice with hindlimb paralysis (A), and the late stage as mice with quadriparesis (B). The medians of the onset of the early stage are 7 days for the 3W group, and 15 days for the 8W group. By 14 days, 50% of mice in the 3W group were quadriparalyzed. The 8W group had a later onset of the late stage with a median of 33 days. The pattern of intoxication was quite consistent as within 19 days all the 3W group became quadriparalyzed. By 43 days, all the 8W mice had paralysis of both fore-and hindlimbs. The progression from the early to the late stage after acrylamide intoxication was faster in the 3W group (median 7.0 days) than in the 8W group (median 17.5 days).
FIG. 3.
Changes in body weight after acrylamide intoxication. The graphs show body weights of mice in the 3-week-old (3W in A) group and in the 8-week-old (8W in B) group during intoxication with acrylamide at 400 ppm. There is a significant reduction in body weights after acrylamide intoxication. The extent of weight reduction is more obvious in the 3W group than in the 8W group at the end of the late stage (open symbols for control mice and filled symbols for acrylamide-treated mice).
To address this issue, we compared the daily dose (Dose) of acrylamide ingestion between the two groups by measuring the daily volume (Vol) of water intake and recording the body weight (BW) of each mouse every day through the experimental period. The daily dose of acrylamide was calculated with the following formula: Dose ϭ 400 ppm ϫ Vol/BW. The water intake of each mouse was 2.5 Ϯ 0.3 ml/day for the 3W group and 7.3 Ϯ 1.5 ml/day for the 8W group (P Ͻ 0.01). The calculated daily dose was 91.8 Ϯ 20.6 mg · kg Ϫ1 · day Ϫ1 for the 3W group, which was not significantly different from that for the 8W group at 90.8 Ϯ 10.9 mg · kg Ϫ1 · day Ϫ1 (P Ͼ 0.5).
Based on the daily dose, the cumulative dose for the early stage was 650.1 Ϯ 145.6 mg/kg in the 3W group and 1417.1 Ϯ 169.9 mg/kg in the 8W group. At late stage, the cumulative dose was 1404.8 Ϯ 314.6 mg/kg in the mice of the 3W group and 2879.7 Ϯ 345.2 mg/kg in the mice of the 8W group.
Abnormal Motor Performance on the Rota-Rod Test
There were motor deficits before the gaits of acrylamide-intoxicated mice became abnormal. When challenged with the rota-rod test in the initial stage, intoxicated mice performed poorly compared with control mice. For the 3W group, the mice had difficulty in maintaining their balance on the rotating rods within 4.1 Ϯ 1.7 days after intoxication. The onset of motor deficits was later in the 8W group, namely, 8.5 Ϯ 1.9 days after intoxication (P Ͻ 0.01, Fig. 4) . The results clearly suggest that abnormalities in motor functions began in the initial stage, although the walking patterns appear normal at this stage.
Early Pathological Changes in Neuromuscular Junctions
To understand pathological alterations in neuromuscular innervation after acrylamide intoxication, we examined the plantar muscles with combined cholinesterase histochemistry and PGP immunocytochemistry. Axonal terminals were demonstrated by immunoreactivity to PGP (brown reaction product) overlying neuromuscular junctions (blue reaction by cholinesterase staining). In control mice, intramuscular nerve bundles consisted of nerve fibers of similar caliber, with their terminals branching inside neuromuscular junctions (Figs. 5A and 5E ). In the initial stage, swelling of axons appeared in the prejunctional portion before motor nerves entered neuromuscular junctions (Figs. 5B and 5F). Axonal swelling extended distally into terminal branches (terminal swelling) and extended proximally (Figs. 5C and 5G ). In the late stage, there were obvious profiles of axonal degeneration with degenerated axons and myelin debris in the intramuscular nerves (Figs. 5D and 5H). For each stage, pathological findings were similar in the 3W and 8W groups.
Pathologic changes of acrylamide intoxication began from axons before they entered neuromuscular junctions (here designated as prejunctional swelling), with 8-11% of neuromuscular junctions showing prejunctional swelling in the initial stage (Fig. 6) . Quantification of the proportion of abnormal neuromuscular junctions indicated that axonal swelling preceded swelling in the terminal branches and denervation of neuromuscular junctions appeared only subsequently. The motor innervation of neuromuscular junctions in the plantar muscles was strikingly decreased after acrylamide intoxication in both groups. In the 3W group, there was a 24% reduction in innervated neuromuscular junctions in the late stage with a similar degree (19%) in the 8W group.
Electron Microscopic Observations on Intramuscular Nerves
We correlated pathological changes with ultrastructural findings of intramuscular nerves. After acrylamide intoxication, there was axonal degeneration in the intramuscular nerves of the plantar muscle (Fig. 7) . In control mice, axons of the intramuscular nerves were well myelinated (Fig. 7A ). There were profiles of axonal degeneration and shrinkage in the intramuscular nerves of acrylamide-intoxicated mice (Fig. 7B) . At the ultrastructural level, degeneration of axons, disorganized organelles, and disintegration of myelin sheaths became obvious after acrylamide intoxication (Fig. 7C) .
FIG. 4.
Performance of the rota-rod test after acrylamide intoxication. The plots show the evolution of motor abnormalities during acrylamide intoxication in mice of the 3-week-old (3W, triangles) and 8-week-old (8W, circles) groups. Mice in the control group could maintain balance on the rotating rod at 8 rpm for more than 120 s, indicated by the dashed line. Within 4 days, mice in the 3W group had difficulty staying on the rotating rod (107 Ϯ 27 s, P Ͻ 0.01). The motor abnormalities worsened and the mice in the 3W group failed to perform the test by 10 days. The motor abnormalities had a later onset in mice of the 8W group. The duration of staying on the rota-rod was significantly shorter within 9 days (103 Ϯ 28 s, P Ͻ 0.01), and the mice in the 8W group were unable to perform the rota-rod test by 35 days.
Neurophysiological Abnormalities after Acrylamide Intoxication
To understand the functional significance of pathological abnormalities, we performed nerve conduction studies on tail nerves. Acrylamide intoxication produces a gradual but significant reduction in the amplitudes of CMAP. In the late stage of the 3W group, there was a 41% decrease in amplitudes of CMAP from 5.9 Ϯ 1.4 to 3.5 Ϯ 1.8 mV (P Ͻ 0.01, Table 2 ). In the 8W group, the reduction in amplitudes was 45%, from 14.2 Ϯ 4.5 to 7.8 Ϯ 1.3 mV (P Ͻ 0.01, Table 2 ).
DISCUSSION
Acrylamide intoxication provides an important experimental approach for studying nerve degeneration, in particular, distal axonopathy. Exposure to acrylamide has profound influence on the nervous system, and the effect is modified by age. The major findings in this report add two more important aspects in understanding the mechanisms: (i) earlier occurrence and faster progression of neurological abnormalities in 3-week-old mice than in 8-week-old mice and (ii) early pathology in motor axons innervating neuromuscular junctions preceding neurological symptoms (Table 3) .
Early Pathological Involvement in Acrylamide Intoxication
In this report, we documented the sequence of motor abnormalities. Consistent with previous studies, the pathological changes began from the most terminal parts of axons and evolved proximally (12, 33) . The involvement was quite early as the paralytic gait was not evident at the initial stage, but sophisticated tests, such as the rota-rod test, could already demonstrate abnormalities of motor performance. The obvious change in the amplitude of nerve-evoked muscle action potential was not apparent until the late stage of intoxication. The reduction in amplitude of muscle potentials is attributed to Wallerian-like degeneration. Of course, dysfunctions of the cerebellum and proprioceptive sensations could also contribute to the abnormal performance after acrylamide intoxication (25) .
Effects of Age on Neurological Abnormalities in Acrylamide Toxicity
This report clearly demonstrates the influence of age on vulnerability to acrylamide intoxication. Only limited reports have addressed this issue (37). Suzuki and Pfaff found that sucking rats had a faster pace of nerve degeneration after acrylamide intoxication (27) . Kaplan and Murphy observed that aging 14-week-old rats were more susceptible to acrylamide than were 5-week-old rats (9) . These findings suggest that age is an important factor in determining the susceptibility to acrylamide and should be taken into consideration when evaluating various dosing schedules (20) . In the present study, the daily dose of acrylamide ingestion was similar in the 3-and 8-week-old mice, suggesting that the age is a decisive factor. From weaning to young adulthood, there are dramatic changes in the organization of the nervous system, including myelination and cytoskeletal compositions. The differential susceptibil- ity should shed light on the possible mechanisms of acrylamide intoxication.
Mechanisms for Differential Vulnerability in Acrylamide Intoxication
The neuropathological hallmarks of acrylamide intoxication are filamentous swelling of axons in paranodal area and the terminal part of axons, distal axonopathy, or dying-back neuropathy. The contents of axonal swelling consist of microtubules, neurofilaments, and mitochondria. Recent observations suggest that microtubules, rather than neurofilaments, play an important role in the pathogenesis of acrylamide intoxication. Compelling evidence comes from a mutant strain of Japanese quail, Quv. The mutant quail lack neurofilaments because of a missense mutation in the low molecular weight neurofilament (NF-L), with premature termination of NF-L synthesis. Despite the absence of neurofilaments, Quv is susceptible to acrylamide as are the normal quail (15) . These results emphasize the important contribution of microtubules in acrylamide intoxication. Microtubules are important in neurite elongation and are more abundant than neurofilaments in young animals (28, 29, 36) . The compositions of microtubules, motors of microtubules, and microtubule-associated proteins change as animals become mature (30, 31, 34) . A recent study suggests that acrylamide has a direct effect on kinesin-based microtubule motility (22) . Taken together, the difference in microtubule organization and related proteins could potentially underlie the differential vulnerability to acrylamide. Further investigations are required to elucidate these points. Nevertheless, the present report establishes an experimental system to produce motor dysfunctions, which is also useful for further therapeutic trials.
